MAPS 2025

MAPS 2025 Decoded: The Medical Affairs Playbook for Successful Drug Launches

At the MAPS Americas 2025 conference in New Orleans, one of the pivotal discussions centered around preparing for drug launches in the current pharmaceutical landscape. While many important topics were covered, a critical element that was notably missing from the discussion was the need for a strategic north star—a guiding philosophy that ensures all tactical…...
Read More

Top Stories

DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...
Biopharma 2025 Trends

Biopharma Trends 2025: 3 Things to Know Right Now

The global business climate is ever-evolving, and 2025 looks...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Medication without Harm

World Patient Safety Day 2022 – Medication Without Harm

Medication use around the world has increased in the last few years; a 2019 CDC...
Patient Inclusivity Survey - PM360 and Cactus Life Sciences

Patient Inclusivity Survey

How many life sciences companies are actually making an effort to include patients in things...
Caregivers, Patient Engagement Day

World Patient Engagement Day 2022

Caregivers play a crucial role in ensuring patient well-being. This World Patient Engagement Day, let’s take...
Why the Healthcare Industry MUST Care About the Caregiver

Why the Healthcare Industry MUST Care About the Caregiver

Caregivers are vital in the treatment of a patient, whether at home or in a...
Image - Understanding Patient Centricity, Progress Made, and Barriers Encountered A Survey of Industry Professionals

Understanding Patient Centricity, Progress Made, and Barriers Encountered: A Survey of Industry Professionals

Cactus Life Sciences conducted a survey of pharma/biotech and associated industry professionals to gather their...
Image - What Makes Stakeholders Trust Pharma-Generated Scientific Content and How Can the Industry Do Better

What Makes Stakeholders Trust Pharma-Generated Scientific Content and How Can the Industry Do Better?

While diverse pharma stakeholders are now consuming scientific content digitally more than ever before, the...

Learn more ABOUT our company.